Prospective cost analysis of moxalactam versus clindamycin plus gentamicin for endomyometritis after cesarean section (Q35308976)

7 August 2017

title

Prospective cost analysis of moxalactam versus clindamycin plus gentamicin for endomyometritis after cesarean section (English)

1 reference

https://api.crossref.org/works/10.1128/AAC.32.6.853

7 August 2017

0 references

0 references

1 reference

1 reference

8 January 2023

author name string

L. C. Knodel

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3415207

8 January 2023

B. R. Goldspiel

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3415207

8 January 2023

R. S. Gibbs

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3415207

8 January 2023

language of work or name

English

0 references

publication date

1 June 1988

1 reference

7 August 2017

number of pages

5

1 reference

full work available at URL

inferred from page(s)

https://europepmc.org/articles/PMC172295

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3415207

https://europepmc.org/articles/PMC172295?pdf=render

8 January 2023

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3415207

https://journals.asm.org/doi/pdf/10.1128/AAC.32.6.853

8 January 2023

1 reference

https://api.crossref.org/works/10.1128/AAC.32.6.853

Antimicrobial Agents and Chemotherapy

8 January 2023

published in

1 reference

7 August 2017

volume

32

1 reference

7 August 2017

issue

6

1 reference

7 August 2017

page(s)

853-857

1 reference

Cost comparison of two antimicrobial regimens for treating mixed aerobic-anaerobic infections

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172295

The influence of dose frequency and agent toxicity on the cost of parenteral antibiotic therapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172295

A double-blind, randomized comparison of clindamycin-gentamicin versus cefamandole for treatment of post-cesarean section endomyometritis.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172295

Therapy of obstetrical infections with moxalactam

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172295

Comparison of moxalactam with the combination of clindamycin and an aminoglycoside in the treatment of common surgical infections

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172295

Cost-containment of antimicrobial therapy.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172295

Randomized, comparative trial of imipenem/cilastatin and moxalactam in the treatment of serious obstetric and gynecologic infections.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172295

Pathophysiology and management of postcesarean endomyometritis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172295

Controversies in antimicrobial therapy: pitfalls in monitoring aminoglycoside therapy

27 July 2018

1 reference

12 December 2020

Moxalactam for Treatment of Pelvic Infections After Cesarean Delivery

1 reference

12 December 2020

A Randomized Clinical Trial of Moxalactam Alone versus Tobramycin plus Clindamycin in Abdominal Sepsis

1 reference

12 December 2020

A double-blind, randomized comparison of moxalactam versus clindamycin-gentamicin in treatment of endomyometritis after cesarean section delivery

1 reference

12 December 2020

Cost of intravenous antibiotic therapy. Frequency of administration as a factor

1 reference

12 December 2020

Economic analysis of a new drug: potential savings in hospital operating costs from the use of a once-daily regimen of a parenteral cephalosporin

1 reference

12 December 2020

Cost containment of reconstituted parenteral antibiotics: personnel and supply costs associated with preparation, dispensing, and administration

1 reference

12 December 2020

Twice-daily moxalactam versus gentamicin and clindamycin in patients with penetrating abdominal trauma

1 reference

12 December 2020

Moxalactam versus clindamycin plus tobramycin in the treatment of obstetric and gynecologic infections

1 reference

12 December 2020

Contamination rates and costs associated with the use of four intermittent intravenous infusion systems

1 reference

12 December 2020

Comparative clinical evaluation of ticarcillin plus clavulanic acid versus clindamycin plus gentamicin in treatment of post-cesarean endomyometritis

1 reference

12 December 2020

Cefoxitin versus clindamycin and gentamicin in the treatment of postcesarean section infections

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.32.6.853

1 reference

7 August 2017

1 reference

7 August 2017

1 reference